Leng Ning, Zhou Weidong, Jiang Lei, Zhao Yongli, Zhou Mingyu, Sun Shanshan, Nie Wen
Department of Oncology, Jiaozhou Central Hospital of Qingdao, Qingdao 266300, Shandong, China.
J BUON. 2021 Mar-Apr;26(2):359-365.
The purpose of this study was to uncover the influence of microRNA-188-5p (miRNA-188-5p) on the metastasis of glioma, thus providing a new direction in the early diagnosis and prediction of disease progression.
MiRNA-188-5p levels in 44 glioma tissues and paracancerous ones were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Its influence on pathological indicators and prognosis in glioma patients was analyzed. In glioma cell lines, regulatory effects of miRNA-188-5p on cell phenotypes were examined by cell counting kit-8 (CCK-8), wound healing and Transwell assay, respectively. Moreover, the interaction between miRNA-188-5p and XRCC5, as well as their involvement in the development of glioma were finally illustrated.
MiRNA-188-5p was downregulated in glioma samples. Glioma patients expressing a low level of miRNA-188-5p had a higher rate of distant metastasis and worse prognosis. Overexpression of miRNA-188-5p remarkably attenuated proliferative and migratory abilities of glioma cells. XRCC5 was the downstream gene of miRNA-188-5p, and its level was negatively regulated by miRNA-188-5p. Besides, XRCC5 was upregulated in glioma samples. Moreover, XRCC5 was responsible for the inhibitory effects of miRNA-188-5p on the metastasis of glioma.
MiRNA-188-5p is linked to distant metastasis and prognosis in glioma patients, and it inhibits the proliferative and migratory abilities of glioma cells by binding XRCC5 and then negatively regulating its level.
本研究旨在揭示微小RNA-188-5p(miRNA-188-5p)对胶质瘤转移的影响,从而为疾病进展的早期诊断和预测提供新方向。
采用定量实时聚合酶链反应(qRT-PCR)检测44例胶质瘤组织及癌旁组织中miRNA-188-5p的水平。分析其对胶质瘤患者病理指标及预后的影响。在胶质瘤细胞系中,分别通过细胞计数试剂盒-8(CCK-8)、伤口愈合实验和Transwell实验检测miRNA-188-5p对细胞表型的调控作用。此外,最终阐明miRNA-188-5p与X射线修复交叉互补蛋白5(XRCC5)之间的相互作用及其在胶质瘤发生发展中的作用。
miRNA-188-5p在胶质瘤样本中表达下调。miRNA-188-5p低表达的胶质瘤患者远处转移率更高,预后更差。miRNA-188-5p过表达显著减弱了胶质瘤细胞的增殖和迁移能力。XRCC5是miRNA-188-5p的下游基因,其水平受miRNA-188-5p负调控。此外,XRCC5在胶质瘤样本中表达上调。而且,XRCC5介导了miRNA-188-5p对胶质瘤转移的抑制作用。
miRNA-188-5p与胶质瘤患者的远处转移和预后相关,它通过与XRCC5结合并负调控其水平来抑制胶质瘤细胞的增殖和迁移能力。